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Background/aim: The most appropriate surgical management of follicular neoplasm/suspicious for follicular neoplasm (FN) lesions is
still contradictory. We aimed to evaluate the data of our patients with follicular neoplasm treated with thyroidectomy.
Materials and methods: We retrospectively analyzed the data of 74 patients who were diagnosed with follicular neoplasm cytology
(FN cytology) by fine needle aspiration biopsy (FNAB) and had undergone total thyroidectomy or lobectomy with isthmectomy (LwI).
Results: We examined a total of 74 patients, of which 64 (83.7%) were female and 10 (16.3%) were male. The malignancy rate in the
pathological examinations of these patients was 31/74 (41.9%). The most common cancer among the patients with malignancy was
papillary thyroid carcinomas (PTC) (20/31, 65%). Among the subtypes of PTCs, 11 were classical PTC, 5 were a follicular variant of
PTC, 2 were the oncocytic variant of PTC, 1 was the diffuse sclerosing variant, and 1 was a columnar cell variant of PTC.
Conclusion: Since most FN cytology has been pathologically diagnosed with papillary cancer and some papillary cancer subtypes have
been unfavorable pathologically, total thyroidectomy should be the most suitable treatment option in this group. Lobectomy with LwI
is not suitable for patients with FNAB-proven FN cytology.
Key words: Follicular neoplasm, lobectomy, thyroid carcinoma

1. Introduction
The incidence of thyroid cancer is increasing around the
world as a result of increased use of ultrasonography.
Thyroid nodules were found in 20%–50% of the population,
depending on both population and environmental
factors (1,2). Fine needle aspiration biopsy (FNAB) is an
inexpensive, minimally invasive outpatient procedure
that determines the malignancy risk in thyroid nodules.
The Bethesda classification for thyroid cytology is used
for the pathologic classification of these nodules (3).
This classification system subdivides the ‘indeterminate’
thyroid cytology in compliance with malignancy risk.
About 5%–15% of cases called atypia or follicular lesion of
undetermined signiﬁcance, 15%–30% suspected follicular
neoplasm (FN) or Hürthle cell neoplasm (HCN) cases,
and 60%–75% suspected malignancy cases prove to be
malignant (4). FN and HCN are relatively uncommon
diseases, and their cytologic diagnosis is difficult in
comparison to papillary thyroid carcinoma (PTC), which
poses a cytologic accuracy higher than 90%. The diagnostic
accuracy and predictive malignancy rates of FN and HCN

are less than those in PTC when a histologic correlation is
performed (5).
According to the American Thyroid Association
Management Guidelines for Adult Patients with Thyroid
Nodules and Differentiated Thyroid Cancer, surgery is
recommended for patients when FN or HCN is diagnosed
with FNAB, which cannot distinguish between benign
and malignant tumors in these cases until the histologic
diagnosis is performed from the surgery’ specimen (6).
However, the most appropriate method of surgery for FN/
follicular neoplasm-suspected lesions is still controversial.
Lobectomy with isthmectomy (LwI) is the minimal
therapeutic accepted procedure for patients with FN
cytology, since FN has a malignancy risk lower than 30%
and is usually unifocal. Malignancy rate was 19% in FN
patients to whom LwI was applied, and this procedure was
thought be adequate in 96% of patients with similar results
to total thyroidectomy (TT) in terms of recurrence and
survival (7,8).
Since multiglandular disease and thyroiditis may be
associated with high malignancy risk, total thyroidectomy
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should be recommended in this case (9). PTC may show
multifocal features and central lymph node metastasis at
the time of diagnosis. Total thyroidectomy appears to be
the most appropriate treatment option for patients with
FN cytology, because most FN cytology was diagnosed
with papillary carcinoma, and some have subtypes with
poor prognosis.
We retrospectively evaluated the pathological
correlation of FN cytology according to the
Bethesda classification system in FNAB with the
pathological findings in thyroidectomy specimens.
2. Materials and methods
We retrospectively analyzed the data of 74 patients who
were diagnosed with FN by FNAB and had undergone total
thyroidectomy or lobectomy with isthmectomy between
2011 and 2013. A retrospective study was conducted at the
Endocrinology Clinic of Dışkapı Yıldırım Beyazıt Teaching
and Research Hospital, Ankara. The study was conducted
in accordance with the Helsinki Declaration. Ethics
committee approval and written informed consent of
participants were obtained prior to the study. Patients with
previous thyroid surgery were excluded. Ultrasonographic
examinations were performed in our clinic with a 13MHz linear transducer (EUB 7000 HV; Hitachi, Tokyo,
Japan). Ultrasound (US) determined the largest and/or
most suspicious-appearing thyroid nodule, defined as a
dominant nodule. FNABs were performed with ultrasound
guidance, using either a 22-gauge needle attached to a 5-mL
disposable plastic syringe or an aspirator. Samples were
stained with hematoxylin and eosin and examined by our
Pathology Department. All FNAB slides were reviewed by
our experienced cytopathologist and regrouped into four
main categories: nondiagnostic, benign, indeterminate,
or malignant, as previously reported. The indeterminate
group included atypia of undetermined significance (AUS)
or follicular lesion of undetermined significance (FLUS),
FN or suspicious for FN, HCN, and suspicious for papillary
thyroid cancer (PTC) (10). Only patients presenting with
follicular neoplasm/suspicious for FN cytology were
included in the study. All operations were performed in
our hospital. Intraoperative frozen section examination
(IFSE) was not performed for diagnosing thyroid cancer
or for determining the extent of thyroidectomy, because
our pathologists consider the usefulness of this procedure
to be very limited in patients with FN.
2.1. Statistical analysis
Statistical analysis was performed using PASW 18
(SPSS, Chicago, IL, USA). Normality was tested with
the Kolmogorov–Smirnov and Shapiro–Wilk W tests.
Data were described as mean and standard deviation
for continuous variables, and as actual numbers and
percentages for categorical variables. The comparison

between the groups was performed with independent
sample t-test and Fisher’s exact test for proportions.
Statistical significance was defined as P < 0.05.
3. Results
Of a total of 74 patients, 64 (83.7%) were female and
10 (16.3%) were male. Mean age was 46.3 ± 12.2 years.
Malignancy rate was 31/74 (41.9%) in the pathological
examinations of these patients. Among the patients with
malignancy, the most common cancer was papillary
thyroid carcinomas (PTC) (20/31, 65%). Only 8 (26%)
were diagnosed with follicular thyroid carcinoma, 2
(6%) were diagnosed with Hürthle cell carcinoma,
and 1 (3%) was diagnosed as a neoplasm of uncertain
malignant potential. Among PTC subtypes, 11 were
classical PTC, 5 were the follicular variant of PTC, 2
were the oncocytic variant of PTC, 1 was the diffuse
sclerosing variant, and 1 was a columnar cell variant, PTC.
4. Discussion
The most appropriate surgery method for FN/follicular
neoplasm-suspected lesions is still controversial. Thyroid
FNAB is very sensitive in distinguishing between benign
and malignant nodules and has limited sensitivity
for follicular lesions. In these patients, clinical and
ultrasonographic features are inadequate in predicting
the malignancy potential of the lesion. According to the
Bethesda system for reporting thyroid cytopathology,
the malignancy risk for categories III and IV is 5%–15%
and 15%–30%, respectively (10). Antunes et al. observed
that malignancy risk was 45.83% in patients with FN
who underwent LwI. Excluding microcarcinomas,
33.33% of patients from category IV were diagnosed with
malignancy (11). Several other studies have also found
higher rates of malignancy in patients with FN. Baloch
et al. found a malignancy risk of 31% in patients with FN
who had undergone TT (12). In another study, by Kim et
al., this rate was found to be 47.9% (13). In our study, the
malignancy rate in patients with FN was 41.9%.
Spanheimer et al. observed that 18.81% of patients
who had undergone LwI for nodular disease required
completion thyroidectomy for thyroid cancer. In the same
study, 42.2% of patients were required to be on lifelong
thyroid hormone replacement therapy, and LwI was
considered as an insufficient surgical method (14).
In a study by Antunes et al., 40.1% of patients who had
undergone LwI for FN required completion thyroidectomy
for thyroid cancer, and no functional benefit was
achieved in 23.1% of these patients because of post-LwI
hypothyroidism. Nodular relapse occurred in 20.35% of
patients undergoing LwI. The authors recommended total
thyroidectomy for patients with FN cytology preoperative
TSH > 2.16 mU/L, and, in Bethesda category IV, younger
than 39.5 years (11). In another study conducted in the
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last period, it was observed that 47% of patients with
indeterminate cytology (Category III and Category IV)
who underwent LwI became hypothyroid postoperatively
(15). According to a meta-analysis, the risk of malignancy
in 2571 patients with FN cytology was 26.1% (16). The
high rate of malignancy in our patients with FN cytology
supports the thesis that total thyroidectomy might be
considered at the forefront.
Approximately 16% of the thyroid nodules evaluated
by FNAB are determined to be follicular neoplasms that
require excisional biopsy, since only histopathological
evidence of capsular and vascular invasion can confirm
malignancy (17,18). LwI is recommended as the minimum
surgical procedure to be performed on FN or suspicious
for FN (10). Several authors suggest the implementation
of total thyroidectomy in these cases, because it eliminates
the possibility of reoperation and the sonographic followup. In a recent study, the authors proposed that total
thyroidectomy is the most cost-effective treatment option
for follicular thyroid nodules (19).
The use of intraoperative frozen section examination
(IFSE) during diagnostic LwI for an FN is contradictory.
Since IFSE may allow intraoperative diagnosis of
malignancy, it may prevent the patient from being

reoperated for completion thyroidectomy. However, the
sensitivity of IFSE is low and it rarely affects the course
of the operation; instead, it adds to costs and extends
operation times. Additionally, possible false positive
results by IFSE may cause an unnecessary thyroid lobe
removal on the contralateral side (20). Thyroid cancer was
diagnosed in 26 (27%) patients, with a diagnosis of FN on
findings from FNAB who underwent surgery (21). In the
light of this information, LwI does not seem to be a viable
surgery option due to the high risk of malignancy and
possible failure of IFSE.
Columnar cell, tall cell, diffuse sclerosing variant
types of PTC, and the widely invasive variant of follicular
carcinoma have a worse prognosis. These variants are
characterized by widely extrathyroidal invasion, vascular
invasion, widely tumor necrosis, and a high grade of
mitosis. Trabecular and insular carcinoma variants are
other undifferentiated aggressive tumor histologies.
(22). Since some of our patients have these subtypes of
aggressive tumors, we think that total thyroidectomy
would be beneficial in terms of mortality and morbidity.
In conclusion, LwI may not be suitable for patients
with FN cytology because of the high malignancy risk in
patients with FN cytology.
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